GlassScriptPhysician profile
Selvaratnam Sinna
NPI 1811929920
$12,639.47
in general payments reported to CMS, 2019-2025
33 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $88.70 · 2021: $354 · 2022: $266 · 2023: $397 · 2024: $704 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $10K · Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $10,000.00 |
| Food and Beverage | $1,397.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $10,000.00 | 2025 | Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $433.36 | 2019-2023 | |
| Boston Scientific Corporation | $213.70 | 2024-2025 | Watchman Flx, Bodyguardian |
| Abbott Laboratories | $211.51 | 2019-2023 | Jot Dx |
| Irhythm Technologies, INC. | $189.66 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $176.28 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $173.34 | 2021-2025 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $164.03 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $124.99 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $122.39 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.49 | 2019-2025 | Lifevest |
| Lantheus Medical Imaging, INC. | $99.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $81.61 | 2019-2023 | Farxiga |
| Medtronic, INC. | $77.56 | 2023-2024 | Claria Mri Quad Crt-D Surescan, Corevalve Evolut R |
| Merck Sharp & Dohme LLC | $55.38 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $49.39 | 2022-2023 | Uptravi, Opsumit |
| Novo Nordisk INC | $44.19 | 2021-2025 | Wegovy |
| Philips North America LLC | $40.63 | 2022-2024 | (Ck7) Extended Holter |
| Daiichi Sankyo INC. | $27.86 | 2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $25.08 | 2025 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $23.90 | 2019 | |
| Abiomed | $22.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.06 | 2019 | |
| Vital Connect, INC | $20.88 | 2025 | Vitalpatch Rtm |
| Biotronik INC. | $19.41 | 2022 | |
| Inspire Medical Systems, INC. | $18.60 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.86 | 2025 | Jardiance |
| Amarin Pharma, INC. | $17.71 | 2020 | |
| Medtronic Vascular, INC. | $14.86 | 2019 | |
| Cardiofocus, INC. | $14.20 | 2019 | |
| Kestra Medical Technology Services, INC. | $14.13 | 2024 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $13.76 | 2023 | Inpefa |
| Vivaquant INC, Dba Rhythm Express | $10.50 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selvaratnam Sinna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.